- Home
- TKLF vs CNSP Comparison
TKLF vs CNSP Comparison
Compare TKLF & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKLF | CNSP |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 8.5M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TKLF | CNSP |
|---|---|---|
| Price | $1.60 | $4.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.6K | ★ 16.9K |
| Earning Date | 12-18-2026 | 11-16-2026 |
| Dividend Yield | ★ 17.01% | N/A |
| EPS Growth | N/A | ★ 8.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $1.90 |
| 52 Week High | $3.49 | $10.54 |
Technical Indicators
Market Signals| Indicator | TKLF | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 34.89 |
| Support Level | $1.30 | $2.01 |
| Resistance Level | $1.64 | $4.00 |
| Average True Range (ATR) | 0.12 | 0.64 |
| MACD | 0.01 | -0.09 |
| Stochastic Oscillator | 40.89 | 12.57 |
Price Performance
Historical ComparisonAbout TKLF Yoshitsu Co. Ltd
Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.